Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eli Lilly And Co (LLY) vs Quanta Services Inc (PWR) Price & Performance

Eli Lilly And CoTrade
Quanta Services IncTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Quanta Services Inc — how do they compare? Eli Lilly And Co trades at $1,179.27 (market cap $1.04T), while Quanta Services Inc trades at $705.94 (market cap $103.03B). The key difference: Eli Lilly And Co is far larger — about 10.1× Quanta Services Inc's market cap, and Eli Lilly And Co pays the higher dividend (0.59%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Quanta Services Inc for 62 Days on average.

LLYPWR
Market Cap
$1.04T$103.03B
Volume
3,064,878977,892
Sector
HealthIndustrials
52-Week High
$1.28K$785.24
52-Week Low
$799.57$412.21
Typical Hold Time
93 Days62 Days
Enterprise Value
$1.09T$109.13B
Dividend Yield
0.59%0.06%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company's weight-loss drug portfolio continues to drive exceptional performance, with Q2 2026 EPS of $8.38 beating expectations by 31%. Technical indicators show bullish moving averages while fundamentals reveal impressive 83.4% gross margins and 102.44% ROE. Recent clinical trial successes for next-generation obesity treatments position Lilly for continued market leadership.

LLY presents a compelling growth story with dominant positioning in the expanding obesity/diabetes market, though elevated valuations (P/E 39.26) and regulatory risks require monitoring. Analyst consensus remains strongly bullish with $1,350 price target representing 15% upside. The primary investment thesis centers on pipeline execution and market expansion opportunities, balanced against competitive pressures and valuation concerns.

Quanta Services Inc

Quanta Services (PWR) trades at $685.33, down 2.25% on the day, but maintains strong technical momentum with bullish moving averages and support at $684. The company demonstrates robust fundamentals with three consecutive quarterly earnings beats, 15.17% ROE, and accelerating revenue growth from $17.1B in 2022 to $28.5B in 2025. Analyst sentiment remains overwhelmingly positive with 27 buy ratings and a $802.08 consensus price target representing 17% upside potential.

PWR presents a compelling growth story with record $53B backlog and AI infrastructure tailwinds, though elevated valuation multiples (P/E 78.41) and execution risks on large projects warrant caution. The stock's proximity to its pivot point at $684 creates a critical technical level that could determine near-term direction.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LLY
22% Buy78% Sell
Avg holding period · 93 Days
PWR
95% Buy5% Sell
Avg holding period · 62 Days

Top news

Latest headlines on both assets

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY →

About Quanta Services Inc

Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two reportable segments: electric power infrastructure solutions and underground utility and infrastructure solutions. In October 2021, the company completed the acquisition of Blattner, a provider of comprehensive engineering, procurement, and construction solutions to customers in the renewable energy industry.

Read more on PWR →